Edition:
United States

Cambrex Corp (CBM.N)

CBM.N on New York Stock Exchange

50.10USD
12:00pm EST
Change (% chg)

$1.15 (+2.35%)
Prev Close
$48.95
Open
$49.35
Day's High
$50.15
Day's Low
$49.35
Volume
74,549
Avg. Vol
79,128
52-wk High
$62.50
52-wk Low
$42.55

Chart for

About

Cambrex Corporation (Cambrex) is a life sciences company. It provides products and services for the development and commercialization of generic therapeutics. It operates through four segments, which are manufacturing facilities that have been aggregated as a single segment. Its manufacturing facilities are owned by the... (more)

Overall

Beta: 2.26
Market Cap(Mil.): $1,602.11
Shares Outstanding(Mil.): 32.73
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 32.50 16.04
EPS (TTM): -- -- --
ROI: -- 15.11 35.70
ROE: -- 16.59 15.40

BRIEF-Cambrex reports Q3 adjusted earnings per share $0.55 from continuing operations

* Q3 adjusted earnings per share $0.55 from continuing operations

Nov 07 2017

BRIEF-Cambrex appoints Gregory Brown to its board of directors

* Gregory B. Brown M.D. Appointed to the board of directors of Cambrex corporation

Nov 03 2017

BRIEF-Cambrex Corp invests $24 mln in a new facility

* ‍To invest $24 million in a new facility to manufacture highly potent APIs at its Charles City, Iowa plant​ Source text for Eikon: Further company coverage:

Aug 08 2017

BRIEF-Cambrex Corp Q2 revenue $134.6 million

* Q2 adjusted earnings per share $0.76 from continuing operations

Aug 04 2017

Earnings vs. Estimates